
UR Advanced Therapeutics PVT LTD is a company focused on engineering personalized medicine through innovative biomaterials and stem cell technologies. They design de novo peptides using computational methods, machine learning, and structural biology for applications in tissue engineering, therapeutics, drug discovery, and companion diagnostics. Their product portfolio includes the Dynamic Apoptosis Detection (DAD)-Kit for apoptosis detection, CytoFLASH a peptide-based fluorescent biosensor for monitoring cell proliferation, ViaBLUE Cell Proliferation Kit for quantifying live cells, and High-Expression Bacterial Vectors for gene over-expression. They also offer wet laboratory services like 2D/3D cell cultures, flow cytometry, and peptide synthesis, as well as in-silico biology services including NGS data analysis and molecular docking.

UR Advanced Therapeutics PVT LTD is a company focused on engineering personalized medicine through innovative biomaterials and stem cell technologies. They design de novo peptides using computational methods, machine learning, and structural biology for applications in tissue engineering, therapeutics, drug discovery, and companion diagnostics. Their product portfolio includes the Dynamic Apoptosis Detection (DAD)-Kit for apoptosis detection, CytoFLASH a peptide-based fluorescent biosensor for monitoring cell proliferation, ViaBLUE Cell Proliferation Kit for quantifying live cells, and High-Expression Bacterial Vectors for gene over-expression. They also offer wet laboratory services like 2D/3D cell cultures, flow cytometry, and peptide synthesis, as well as in-silico biology services including NGS data analysis and molecular docking.